Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- Check3 days agoChange DetectedA government funding/operating-status notice was removed from the page; this does not affect the study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoChange DetectedRemoved 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics' from the page's keywords/MeSH terms.SummaryDifference0.1%

- Check17 days agoChange DetectedNo additions or deletions detected between the old and new screenshots of the study page.SummaryDifference0.2%

- Check32 days agoChange Detected- Removed a MedlinePlus Genetics related topic: Type 2 diabetes, reducing the list of genetic topics covered on the page. This is a high-importance change as it eliminates a core health topic.SummaryDifference0.2%

- Check46 days agoChange DetectedCore page content updated to v3.2.0 and a new MedlinePlus Genetics topic (Type 2 diabetes) added; a government operating status notice was also added. Previous version v3.1.0 was removed.SummaryDifference3%

- Check53 days agoChange DetectedAdded a new revision tag (v3.1.0) and removed the older tag (v3.0.2) along with a topic (MedlinePlus Genetics: Type 2 diabetes); overall, mainly versioning changes with a minor content removal rather than new core material.SummaryDifference0.3%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.